Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India

Natco Pharma launches (Hepcinat Plus Tablet) Hepatitis C drug in India

Natco Phrama launched the drug for the treatment of Hepatitis C Virus. It is a fixed combination of Sofosbuvir-Daclatasvir tablets under the brand name of Hepcinat Plus in India.

The product is a generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg tablets used for the treatment of patients with chronic Hepatitis C virus infection, the company said in a filing to the BSE.

Natco Phrama has launched Hepnicat Plus Tablet at the price of Rs. 17,500; it contains a bottle of 28 tablets.

 

Hepcinat Plus (Sofosbuvir & Daclatasvir) Details:

Brand Name: Hepcinat Plus
Composition: Sofosbuvir 400mg & Daclatasvir 60mg
Manufactured by: Natco Pharma Ltd.
Packing: Pack of 28 Tablets
Country of Origin: India

    

Request for Quote

Our App

Connect with us

Oddway on facebook Oddway on pinterest Oddway on VK Oddway on LinkedIn Oddway on Twitter

Contact Us

  • icon
    Address : 4216/20, Ground Floor, 1 Ansari Road, Daryaganj,
               New Delhi - 110002 (India)
  • icon
    Phone : +91-11-43526658
    Mobile : +91-9873336444
  • icon
    WhatsApp : +91-9873336444
    Viber          : +91-9873336444

Oddway International is a Pharmaceutical Exporter & Supplier of Generic Medicine and Online Pharmacy Distributor in India...Read More

Top